Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends)
Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What vendors are winning? What systems are seeing usage and for what applications? How are labs responding to business pressures and regulatory challenges? What disease areas are seeing the most applications? What are labs future purchasing plans and how are clinical applications driving these decisions?
This study, Next Generation Sequencing Trends focuses on an email and telephone consultation of 110 laboratories which was carried out from April to June of 2013, with the majority in the latter portion. The survey effort targeted labs likely to be doing, or likely to be planning, applications of sequencing in either diagnostic or clinical research settings. Due to the increasing importance of 2nd and 3rd-generation systems in the market, the scope leans towards these types of sequencers. There are only 13 laboratories that have exclusively capillary systems, but these systems are still widely used. About 30% of the systems in the respondents’ labs overall are capillary systems. The mix of labs reached in the surveys provides both a range of industry segments as well as groups of labs with both types of systems.
The survey asked labs about the following trends in Next Generation Sequencing and provides insights into the status of sequencing applications, including the following:
The survey was conducted by Justin Saeks the author of Kalorama Information's DNA Sequencing and Equipment Markets, published in several editions. The survey effort targeted any lab that uses a sequencer for any application, but with the goal of achieving as close a representative breadth of labs as possible. Due to the increasing importance of next generation systems in the market, the scope leans towards these types of sequencers. However, the market inevitably includes labs that use capillary systems as well.
Labs were mostly contacted by phone and asked to participate in a phone interview/survey for around 10 to 15 minutes. A small fraction of the labs completed the survey on a website set up with the questions. The survey included both open-ended and multiple-choice type questions. In most cases, 49% of labs, the lab manager was the party interviewed. Research scientists or associates were spoken to in 35% of cases. The remaining respondents were technicians, executives, professors or others.
Related Reports:The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
May 8, 2013 - KLI5036103 - $4,500.00
DNA Sequencing Market Research Bundle: DNA Sequencing Equipment and Services, 3rd. Edition (Systems, Consumables and Services Markets), Survey of Labs on DNA Sequencer Trends and Survey of Labs on Sample Prep and Library Preparation Trends
Feb 27, 2013 - KLI4979945 - $2,995.00
DNA Sequencing Markets (Next-Generation Systems, Capillary Systems, Consumables, Services)
Sep 7, 2012 - KLI4871738 - $1,995.00
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
Jul 1, 2011 - KLI6450720 - $2,995.00
Sample Preparation and Library Preparation for DNA Sequencers (Results of The Kalorama Survey of Labs)
Jan 1, 2011 - KLI2880500 - $1,995.00
DNA Sequencing Equipment and Services Markets, 2nd Edition
Aug 1, 2009 - KLI2122235 - $3,800.00
Key Genetic Technologies Market Research Bundle (SNPs, Gene Expression Profiling, DNA Sequencing and Analytical Chips)
Nov 1, 2008 - KLI1689637 - $4,995.00
Testing Services Markets, SNP Analysis, DNA Sequencing, Retail Clinics, Companion Diagnostics
Aug 1, 2008 - KLI1836320 - $2,995.00
DNA Sequencing Equipment and Services Markets
Jun 1, 2007 - KLI1430102 - $3,200.00
Questions?Contact a research specialist >
Most Popular ResearchWhy Epigenomics May Be a Game-Changer in Diagnostics and Pharmaceuticals World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing) White Paper: DNA Sequencing Moves into Clinical Applications White Paper: Sequencing Market Benefits From High-Profile Projects The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives White Paper: Tests That Personalize Show Faster Revenue Growth